Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK501483PMID: 30000543
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 60205-81-4
Drug Levels and Effects
Summary of Use during Lactation
Although no published data exist on the use of ipratropium, its use produces negligible maternal serum levels and any drug in breastmilk would not be absorbed by the infant. The risk to the breastfed infant of maternal ipratropium inhalation is small. Breastfeeding can be continued during ipratropium therapy.[1]
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
References
- 1.
- Bendien SA, de Kruif MD, Feitsma H, et al. Summary of the Dutch Multidisciplinary Practice Guideline on Asthma and Pregnancy. J Allergy Clin Immunol Pract 2024;12:1751-62 [PubMed: 38513758]
Substance Identification
Substance Name
Ipratropium
CAS Registry Number
60205-81-4
Drug Class
Breast Feeding
Milk, Human
Anti-Asthmatic Agents
Bronchodilator Agents
Muscarinic Antagonists
Parasympatholytics
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Aclidinium.[Drugs and Lactation Database (...]Review Aclidinium.. Drugs and Lactation Database (LactMed®). 2006
- Review Umeclidinium.[Drugs and Lactation Database (...]Review Umeclidinium.. Drugs and Lactation Database (LactMed®). 2006
- Compatible Stability and Aerosol Characteristics of Atrovent(®) (Ipratropium Bromide) Mixed with Salbutamol Sulfate, Terbutaline Sulfate, Budesonide, and Acetylcysteine.[Pharmaceutics. 2020]Compatible Stability and Aerosol Characteristics of Atrovent(®) (Ipratropium Bromide) Mixed with Salbutamol Sulfate, Terbutaline Sulfate, Budesonide, and Acetylcysteine.Chen Y, Du S, Zhang Z, He W, Lu E, Wang R, Sha X, Ma Y. Pharmaceutics. 2020 Aug 15; 12(8). Epub 2020 Aug 15.
- Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution.[Thorax. 1988]Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution.Rafferty P, Beasley R, Holgate ST. Thorax. 1988 Jun; 43(6):446-50.
- Ipratropium bromide (Atrovent) as inhalation powder. A double-blind study of comparison with ipratropium as a pressure aerosol in patients with reversible airways obstruction.[Allergy. 1986]Ipratropium bromide (Atrovent) as inhalation powder. A double-blind study of comparison with ipratropium as a pressure aerosol in patients with reversible airways obstruction.Maesen FP, Smeets JJ, Bernsen R, Cornelissen PJ. Allergy. 1986 Jan; 41(1):37-42.
- Ipratropium - Drugs and Lactation Database (LactMed®)Ipratropium - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...